Circulating Biomarkers for Immunotherapy Resistance in Liver Cancer - Clinical Trial
What is the Purpose of this Study?
We are doing this study to track changes in the make-up of your tumor that occur during your treatment.
Hepatocellular Carcinoma (Liver Cancer)
Who Can Participate in the Study?
Adults with hepatocellular carcinoma (liver cancer) who will begin treatment with an immune checkpoint inhibitor.
What is Involved?
If you choose to join this study, you will:
- Provide samples of blood, stool, and tumor tissue
- Have your progress tracked by the study team.
You may also be asked to undergo a tumor biopsy.